Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.395
+0.135 (5.97%)
Oct 14, 2025, 4:00 PM EDT - Market closed
Nkarta Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
157
Market Cap
170.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
NKTX News
- 6 weeks ago - Nkarta to Participate in a September Investor Conference - GlobeNewsWire
- 2 months ago - Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 2 months ago - Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series - GlobeNewsWire
- 3 months ago - Nkarta: Holding Its Support Steady Ahead Of First Data Readouts In 2025 - Seeking Alpha
- 4 months ago - Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus - GlobeNewsWire
- 5 months ago - Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space - Benzinga
- 5 months ago - Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 7 months ago - Nkarta to Participate in an April Investor Conference - GlobeNewsWire